TORS as a Primary Treatment Modality in the Treatment of HPV-Related Oral Pharynx Cancers

Otolaryngologist Carole Fakhry, M.D., discusses the use of transoral robotic surgery (TORS) in the treatment of HPV-related oral pharynx cancer, and how its use can de-intensify and reduce morbidities from typically used adjuvant treatment therapies.

Created by

Johns Hopkins Medicine

Related Presenters

Carole Fakhry, MD, MPH

Carole Fakhry, MD, MPH

Director, Johns Hopkins Head and Neck Cancer Center

Chief, Division of Head and Neck Surgery

Professor of Otolaryngology - Head and Neck Surgery

View full profile